Stocks · Health care · Pharmaceutical Preparations

Arcutis Biotherapeutics, Inc.

ARQT Clue Score48
United States Fiscal year ends December CIK 0001787306 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Masaru Matsuda
4 Nov 2026
EVP, Chief Legal Officer
Sold after exercise
40,000
$34.32
$1.37M
Todd Watanabe
2 Nov 2026
See Remarks
Sell
4,377
$31.86
$139.47K
Patrick Burnett
2 Nov 2026
EVP, Chief Medical Officer
Sell
943
$31.86
$30.05K
Masaru Matsuda
2 Nov 2026
EVP, Chief Legal Officer
Sold on a plan
1,219
$31.86
$38.84K
Howard G. Welgus
15 Oct 2026
Director
Sold after exercise
4,728
$26.93
$127.33K

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 2
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 46,913
History held since 3 Feb 2020